Premium
The feared five fungal infections in kidney transplant recipients: A single‐center 20‐year experience
Author(s) -
Parajuli Sandesh,
Wick Alexandra,
Pandeya Sameer,
Astor Brad C.,
Smith Jeannina,
Djamali Arjang,
Mandelbrot Didier A.
Publication year - 2018
Publication title -
clinical transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 76
eISSN - 1399-0012
pISSN - 0902-0063
DOI - 10.1111/ctr.13289
Subject(s) - histoplasmosis , medicine , aspergillosis , blastomycosis , cryptococcosis , mycosis , amphotericin b , mucormycosis , surgery , kidney transplantation , univariate analysis , sporotrichosis , transplantation , immunology , multivariate analysis , dermatology , antifungal
Invasive fungal infections are a feared complication in kidney transplant recipients ( KTR s). Here we present the University of Wisconsin experience with 5 invasive fungal infections—aspergillosis, cryptococcosis, histoplasmosis, blastomycosis, and coccidioidomycosis—in KTR s transplanted between 01/01/1994 and 06/30/2014. During this period, there were 128 cases of fungal infections; aspergillosis was the most common (72), followed by cryptococcosis (29), histoplasmosis (14), blastomycosis (10), and coccidioidomycosis (3). The mean interval from transplant to fungal infection was 3.19 ± 3.58 years (range 5 days‐15.8 years). By 6 months postinfection, there were 53 (41%) graft failures and 24 (19%) deaths. Graft failure occurred in 46%, 38%, 21%, 40%, and 67% of patients with aspergillosis, cryptococcosis, histoplasmosis, blastomycosis, and coccidioidomycosis, respectively. Anti‐thymocyte globulin ( ATG ) induction ( HR , 1.49; 95% CI , 1.03‐2.16; P = .04), diabetes ( HR , 1.53; 95% CI , 1.05‐2.21; P = .03), and age ( HR , 1.47; 95% CI , 1.27‐1.70; P ≤ .001) were associated with an increased risk for infection in univariate analysis. Multivariate adjustment retained ATG induction and older age. A large proportion of kidney transplant recipients with invasive fungal infections suffer graft failure within 3 years. Preventive, therapeutic, and monitoring strategies are needed to improve graft and patient outcomes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom